AustralieFrV1, PascalFrancis, Corpus, bibRecord, 005C05

TOX-ACLS: Toxicologic-oriented advanced cardiac life support

Identifieur interne : 005C05 ( PascalFrancis/Corpus ); précédent : 005C04; suivant : 005C06

TOX-ACLS: Toxicologic-oriented advanced cardiac life support

Auteurs : Timothy E. Albertson ; Andrew Dawson ; Francisco De Latorre ; Robert S. Hoffman ; Judd E. Hollander ; Albert Jaeger ; William Ii Kern ; Thomas G. Martin ; Mitchell P. Ross

Source :

Annals of emergency medicine [ 0196-0644 ] ; 2001.

RBID : Pascal:01-0247194

Descripteurs français

Pascal (Inist)
- Toxicomanie, Intoxication médicamenteuse, Cocaïne, Opiacés, Antagoniste calcium, Stimulant β-adrénergique, Récepteur β-adrénergique, Insuffisance respiratoire, Antidépresseur, Composé tricyclique, Cardiotonique, Complication, Recommandation, Traitement, Evolution, Homme, Ester.

English descriptors

KwdEn :
- Antidepressant agent, Calcium antagonist, Cardiotonic agent, Cocaine, Complication, Drug addiction, Drug intoxication, Ester, Evolution, Human, Opiates, Recommendation, Respiratory failure, Treatment, Tricyclic compound, β-Adrenergic receptor, β-Adrenergic receptor agonist.

Notice en format standard (ISO 2709)

Pour connaître la documentation sur le format Inist Standard.

A01	`01`	`1`		`@0 0196-0644`
A02	`01`			`@0 AEMED3`
A03		`1`		`@0 Ann. emerg. med.`
A05				`@2 37`
A06				`@2 4 @3 SUP`
A08	`01`	`1`	`ENG`	`@1 TOX-ACLS: Toxicologic-oriented advanced cardiac life support`
A11	`01`	`1`		`@1 ALBERTSON (Timothy E.)`
A11	`02`	`1`		`@1 DAWSON (Andrew)`
A11	`03`	`1`		`@1 DE LATORRE (Francisco)`
A11	`04`	`1`		`@1 HOFFMAN (Robert S.)`
A11	`05`	`1`		`@1 HOLLANDER (Judd E.)`
A11	`06`	`1`		`@1 JAEGER (Albert)`
A11	`07`	`1`		`@1 KERN (William II)`
A11	`08`	`1`		`@1 MARTIN (Thomas G.)`
A11	`09`	`1`		`@1 ROSS (Mitchell P.)`
A14	`01`			`@1 University of California Davis Medical Center @2 Sacramento, CA @3 USA @Z 1 aut.`
A14	`02`			`@1 Newcastle Mater Misericordiae Hospital @2 Newcastle @3 AUS @Z 2 aut.`
A14	`03`			`@1 Universitario Val d'Hebron @2 Barcelona @3 ESP @Z 3 aut.`
A14	`04`			`@1 New York Poison Center @2 New York, NY @3 USA @Z 4 aut.`
A14	`05`			`@1 University of Pennsylvania @2 Philadelphia, PA @3 USA @Z 5 aut.`
A14	`06`			`@1 Hospitaux Universitaires de Strasbourg @2 Strasbourg @3 FRA @Z 6 aut.`
A14	`07`			`@1 Carolinas Medical Center @2 Charlotte, NC @3 USA @Z 7 aut.`
A14	`08`			`@1 University of Washington Medical Center @2 Seattle, WA @3 USA @Z 8 aut.`
A14	`09`			`@1 University of Louisville @2 Louisville, KY @3 USA @Z 9 aut.`
A20				`@2 S78-S90`
A21				`@1 2001`
A23	`01`			`@0 ENG`
A43	`01`			`@1 INIST @2 19670 @5 354000098814500100`
A44				`@0 0000 @1 © 2001 INIST-CNRS. All rights reserved.`
A45				`@0 110 ref.`
A47	`01`	`1`		`@0 01-0247194`
A60				`@1 P`
A61				`@0 A`
A64	`01`	`1`		`@0 Annals of emergency medicine`
A66	`01`			`@0 USA`
C02	`01`	`X`		`@0 002B27B15`
C02	`02`	`X`		`@0 002B02V`
C03	`01`	`X`	`FRE`	`@0 Toxicomanie @5 01`
C03	`01`	`X`	`ENG`	`@0 Drug addiction @5 01`
C03	`01`	`X`	`SPA`	`@0 Toxicomanía @5 01`
C03	`02`	`X`	`FRE`	`@0 Intoxication médicamenteuse @5 02`
C03	`02`	`X`	`ENG`	`@0 Drug intoxication @5 02`
C03	`02`	`X`	`SPA`	`@0 Intoxicación medicamentosa @5 02`
C03	`03`	`X`	`FRE`	`@0 Cocaïne @2 NK @2 FR @2 FX @5 04`
C03	`03`	`X`	`ENG`	`@0 Cocaine @2 NK @2 FR @2 FX @5 04`
C03	`03`	`X`	`SPA`	`@0 Cocaína @2 NK @2 FR @2 FX @5 04`
C03	`04`	`X`	`FRE`	`@0 Opiacés @5 05`
C03	`04`	`X`	`ENG`	`@0 Opiates @5 05`
C03	`04`	`X`	`SPA`	`@0 Opiados @5 05`
C03	`05`	`X`	`FRE`	`@0 Antagoniste calcium @5 07`
C03	`05`	`X`	`ENG`	`@0 Calcium antagonist @5 07`
C03	`05`	`X`	`SPA`	`@0 Antagonista calcio @5 07`
C03	`06`	`X`	`FRE`	`@0 Stimulant β-adrénergique @5 08`
C03	`06`	`X`	`ENG`	`@0 β-Adrenergic receptor agonist @5 08 @6 «β»-Adrenergic receptor agonist`
C03	`06`	`X`	`SPA`	`@0 Estimulante β-adrenérgico @5 08`
C03	`07`	`X`	`FRE`	`@0 Récepteur β-adrénergique @5 09`
C03	`07`	`X`	`ENG`	`@0 β-Adrenergic receptor @5 09 @6 «β-»Adrenergic receptor`
C03	`07`	`X`	`SPA`	`@0 Receptor β-adrenérgico @5 09`
C03	`08`	`X`	`FRE`	`@0 Insuffisance respiratoire @5 10`
C03	`08`	`X`	`ENG`	`@0 Respiratory failure @5 10`
C03	`08`	`X`	`SPA`	`@0 Insuficiencia respiratoria @5 10`
C03	`09`	`X`	`FRE`	`@0 Antidépresseur @5 11`
C03	`09`	`X`	`ENG`	`@0 Antidepressant agent @5 11`
C03	`09`	`X`	`SPA`	`@0 Antidepresor @5 11`
C03	`10`	`X`	`FRE`	`@0 Composé tricyclique @5 12`
C03	`10`	`X`	`ENG`	`@0 Tricyclic compound @5 12`
C03	`10`	`X`	`SPA`	`@0 Compuesto tricíclico @5 12`
C03	`11`	`X`	`FRE`	`@0 Cardiotonique @5 13`
C03	`11`	`X`	`ENG`	`@0 Cardiotonic agent @5 13`
C03	`11`	`X`	`SPA`	`@0 Cardiotónico @5 13`
C03	`12`	`X`	`FRE`	`@0 Complication @5 16`
C03	`12`	`X`	`ENG`	`@0 Complication @5 16`
C03	`12`	`X`	`SPA`	`@0 Complicación @5 16`
C03	`13`	`X`	`FRE`	`@0 Recommandation @5 17`
C03	`13`	`X`	`ENG`	`@0 Recommendation @5 17`
C03	`13`	`X`	`SPA`	`@0 Recomendación @5 17`
C03	`14`	`X`	`FRE`	`@0 Traitement @5 18`
C03	`14`	`X`	`ENG`	`@0 Treatment @5 18`
C03	`14`	`X`	`SPA`	`@0 Tratamiento @5 18`
C03	`15`	`X`	`FRE`	`@0 Evolution @5 19`
C03	`15`	`X`	`ENG`	`@0 Evolution @5 19`
C03	`15`	`X`	`SPA`	`@0 Evolución @5 19`
C03	`16`	`X`	`FRE`	`@0 Homme @5 20`
C03	`16`	`X`	`ENG`	`@0 Human @5 20`
C03	`16`	`X`	`SPA`	`@0 Hombre @5 20`
C03	`17`	`X`	`FRE`	`@0 Ester @5 27`
C03	`17`	`X`	`ENG`	`@0 Ester @5 27`
C03	`17`	`X`	`SPA`	`@0 Ester @5 27`
C07	`01`	`X`	`FRE`	`@0 Appareil respiratoire pathologie @5 61`
C07	`01`	`X`	`ENG`	`@0 Respiratory disease @5 61`
C07	`01`	`X`	`SPA`	`@0 Aparato respiratorio patología @5 61`
N21				`@1 169`

Format Inist (serveur)

NO :	PASCAL 01-0247194 INIST
ET :	TOX-ACLS: Toxicologic-oriented advanced cardiac life support
AU :	ALBERTSON (Timothy E.); DAWSON (Andrew); DE LATORRE (Francisco); HOFFMAN (Robert S.); HOLLANDER (Judd E.); JAEGER (Albert); KERN (William II); MARTIN (Thomas G.); ROSS (Mitchell P.)
AF :	University of California Davis Medical Center/Sacramento, CA/Etats-Unis (1 aut.); Newcastle Mater Misericordiae Hospital/Newcastle/Australie (2 aut.); Universitario Val d'Hebron/Barcelona/Espagne (3 aut.); New York Poison Center/New York, NY/Etats-Unis (4 aut.); University of Pennsylvania/Philadelphia, PA/Etats-Unis (5 aut.); Hospitaux Universitaires de Strasbourg/Strasbourg/France (6 aut.); Carolinas Medical Center/Charlotte, NC/Etats-Unis (7 aut.); University of Washington Medical Center/Seattle, WA/Etats-Unis (8 aut.); University of Louisville/Louisville, KY/Etats-Unis (9 aut.)
DT :	Publication en série; Niveau analytique
SO :	Annals of emergency medicine; ISSN 0196-0644; Coden AEMED3; Etats-Unis; Da. 2001; Vol. 37; No. 4 SUP; S78-S90; Bibl. 110 ref.
LA :	Anglais
CC :	002B27B15; 002B02V
FD :	Toxicomanie; Intoxication médicamenteuse; Cocaïne; Opiacés; Antagoniste calcium; Stimulant β-adrénergique; Récepteur β-adrénergique; Insuffisance respiratoire; Antidépresseur; Composé tricyclique; Cardiotonique; Complication; Recommandation; Traitement; Evolution; Homme; Ester
FG :	Appareil respiratoire pathologie
ED :	Drug addiction; Drug intoxication; Cocaine; Opiates; Calcium antagonist; β-Adrenergic receptor agonist; β-Adrenergic receptor; Respiratory failure; Antidepressant agent; Tricyclic compound; Cardiotonic agent; Complication; Recommendation; Treatment; Evolution; Human; Ester
EG :	Respiratory disease
SD :	Toxicomanía; Intoxicación medicamentosa; Cocaína; Opiados; Antagonista calcio; Estimulante β-adrenérgico; Receptor β-adrenérgico; Insuficiencia respiratoria; Antidepresor; Compuesto tricíclico; Cardiotónico; Complicación; Recomendación; Tratamiento; Evolución; Hombre; Ester
LO :	INIST-19670.354000098814500100
ID :	01-0247194

Links to Exploration step

Pascal:01-0247194

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">TOX-ACLS: Toxicologic-oriented advanced cardiac life support</title>
<author><name sortKey="Albertson, Timothy E" sort="Albertson, Timothy E" uniqKey="Albertson T" first="Timothy E." last="Albertson">Timothy E. Albertson</name>
<affiliation><inist:fA14 i1="01"><s1>University of California Davis Medical Center</s1>
<s2>Sacramento, CA</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Dawson, Andrew" sort="Dawson, Andrew" uniqKey="Dawson A" first="Andrew" last="Dawson">Andrew Dawson</name>
<affiliation><inist:fA14 i1="02"><s1>Newcastle Mater Misericordiae Hospital</s1>
<s2>Newcastle</s2>
<s3>AUS</s3>
<sZ>2 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="De Latorre, Francisco" sort="De Latorre, Francisco" uniqKey="De Latorre F" first="Francisco" last="De Latorre">Francisco De Latorre</name>
<affiliation><inist:fA14 i1="03"><s1>Universitario Val d'Hebron</s1>
<s2>Barcelona</s2>
<s3>ESP</s3>
<sZ>3 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Hoffman, Robert S" sort="Hoffman, Robert S" uniqKey="Hoffman R" first="Robert S." last="Hoffman">Robert S. Hoffman</name>
<affiliation><inist:fA14 i1="04"><s1>New York Poison Center</s1>
<s2>New York, NY</s2>
<s3>USA</s3>
<sZ>4 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Hollander, Judd E" sort="Hollander, Judd E" uniqKey="Hollander J" first="Judd E." last="Hollander">Judd E. Hollander</name>
<affiliation><inist:fA14 i1="05"><s1>University of Pennsylvania</s1>
<s2>Philadelphia, PA</s2>
<s3>USA</s3>
<sZ>5 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Jaeger, Albert" sort="Jaeger, Albert" uniqKey="Jaeger A" first="Albert" last="Jaeger">Albert Jaeger</name>
<affiliation><inist:fA14 i1="06"><s1>Hospitaux Universitaires de Strasbourg</s1>
<s2>Strasbourg</s2>
<s3>FRA</s3>
<sZ>6 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Kern, William Ii" sort="Kern, William Ii" uniqKey="Kern W" first="William Ii" last="Kern">William Ii Kern</name>
<affiliation><inist:fA14 i1="07"><s1>Carolinas Medical Center</s1>
<s2>Charlotte, NC</s2>
<s3>USA</s3>
<sZ>7 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Martin, Thomas G" sort="Martin, Thomas G" uniqKey="Martin T" first="Thomas G." last="Martin">Thomas G. Martin</name>
<affiliation><inist:fA14 i1="08"><s1>University of Washington Medical Center</s1>
<s2>Seattle, WA</s2>
<s3>USA</s3>
<sZ>8 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Ross, Mitchell P" sort="Ross, Mitchell P" uniqKey="Ross M" first="Mitchell P." last="Ross">Mitchell P. Ross</name>
<affiliation><inist:fA14 i1="09"><s1>University of Louisville</s1>
<s2>Louisville, KY</s2>
<s3>USA</s3>
<sZ>9 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">INIST</idno>
<idno type="inist">01-0247194</idno>
<date when="2001">2001</date>
<idno type="stanalyst">PASCAL 01-0247194 INIST</idno>
<idno type="RBID">Pascal:01-0247194</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">005C05</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">TOX-ACLS: Toxicologic-oriented advanced cardiac life support</title>
<author><name sortKey="Albertson, Timothy E" sort="Albertson, Timothy E" uniqKey="Albertson T" first="Timothy E." last="Albertson">Timothy E. Albertson</name>
<affiliation><inist:fA14 i1="01"><s1>University of California Davis Medical Center</s1>
<s2>Sacramento, CA</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Dawson, Andrew" sort="Dawson, Andrew" uniqKey="Dawson A" first="Andrew" last="Dawson">Andrew Dawson</name>
<affiliation><inist:fA14 i1="02"><s1>Newcastle Mater Misericordiae Hospital</s1>
<s2>Newcastle</s2>
<s3>AUS</s3>
<sZ>2 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="De Latorre, Francisco" sort="De Latorre, Francisco" uniqKey="De Latorre F" first="Francisco" last="De Latorre">Francisco De Latorre</name>
<affiliation><inist:fA14 i1="03"><s1>Universitario Val d'Hebron</s1>
<s2>Barcelona</s2>
<s3>ESP</s3>
<sZ>3 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Hoffman, Robert S" sort="Hoffman, Robert S" uniqKey="Hoffman R" first="Robert S." last="Hoffman">Robert S. Hoffman</name>
<affiliation><inist:fA14 i1="04"><s1>New York Poison Center</s1>
<s2>New York, NY</s2>
<s3>USA</s3>
<sZ>4 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Hollander, Judd E" sort="Hollander, Judd E" uniqKey="Hollander J" first="Judd E." last="Hollander">Judd E. Hollander</name>
<affiliation><inist:fA14 i1="05"><s1>University of Pennsylvania</s1>
<s2>Philadelphia, PA</s2>
<s3>USA</s3>
<sZ>5 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Jaeger, Albert" sort="Jaeger, Albert" uniqKey="Jaeger A" first="Albert" last="Jaeger">Albert Jaeger</name>
<affiliation><inist:fA14 i1="06"><s1>Hospitaux Universitaires de Strasbourg</s1>
<s2>Strasbourg</s2>
<s3>FRA</s3>
<sZ>6 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Kern, William Ii" sort="Kern, William Ii" uniqKey="Kern W" first="William Ii" last="Kern">William Ii Kern</name>
<affiliation><inist:fA14 i1="07"><s1>Carolinas Medical Center</s1>
<s2>Charlotte, NC</s2>
<s3>USA</s3>
<sZ>7 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Martin, Thomas G" sort="Martin, Thomas G" uniqKey="Martin T" first="Thomas G." last="Martin">Thomas G. Martin</name>
<affiliation><inist:fA14 i1="08"><s1>University of Washington Medical Center</s1>
<s2>Seattle, WA</s2>
<s3>USA</s3>
<sZ>8 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Ross, Mitchell P" sort="Ross, Mitchell P" uniqKey="Ross M" first="Mitchell P." last="Ross">Mitchell P. Ross</name>
<affiliation><inist:fA14 i1="09"><s1>University of Louisville</s1>
<s2>Louisville, KY</s2>
<s3>USA</s3>
<sZ>9 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
</analytic>
<series><title level="j" type="main">Annals of emergency medicine</title>
<title level="j" type="abbreviated">Ann. emerg. med.</title>
<idno type="ISSN">0196-0644</idno>
<imprint><date when="2001">2001</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><title level="j" type="main">Annals of emergency medicine</title>
<title level="j" type="abbreviated">Ann. emerg. med.</title>
<idno type="ISSN">0196-0644</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Antidepressant agent</term>
<term>Calcium antagonist</term>
<term>Cardiotonic agent</term>
<term>Cocaine</term>
<term>Complication</term>
<term>Drug addiction</term>
<term>Drug intoxication</term>
<term>Ester</term>
<term>Evolution</term>
<term>Human</term>
<term>Opiates</term>
<term>Recommendation</term>
<term>Respiratory failure</term>
<term>Treatment</term>
<term>Tricyclic compound</term>
<term>β-Adrenergic receptor</term>
<term>β-Adrenergic receptor agonist</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Toxicomanie</term>
<term>Intoxication médicamenteuse</term>
<term>Cocaïne</term>
<term>Opiacés</term>
<term>Antagoniste calcium</term>
<term>Stimulant β-adrénergique</term>
<term>Récepteur β-adrénergique</term>
<term>Insuffisance respiratoire</term>
<term>Antidépresseur</term>
<term>Composé tricyclique</term>
<term>Cardiotonique</term>
<term>Complication</term>
<term>Recommandation</term>
<term>Traitement</term>
<term>Evolution</term>
<term>Homme</term>
<term>Ester</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
</TEI>
<inist><standard h6="B"><pA><fA01 i1="01" i2="1"><s0>0196-0644</s0>
</fA01>
<fA02 i1="01"><s0>AEMED3</s0>
</fA02>
<fA03 i2="1"><s0>Ann. emerg. med.</s0>
</fA03>
<fA05><s2>37</s2>
</fA05>
<fA06><s2>4</s2>
<s3>SUP</s3>
</fA06>
<fA08 i1="01" i2="1" l="ENG"><s1>TOX-ACLS: Toxicologic-oriented advanced cardiac life support</s1>
</fA08>
<fA11 i1="01" i2="1"><s1>ALBERTSON (Timothy E.)</s1>
</fA11>
<fA11 i1="02" i2="1"><s1>DAWSON (Andrew)</s1>
</fA11>
<fA11 i1="03" i2="1"><s1>DE LATORRE (Francisco)</s1>
</fA11>
<fA11 i1="04" i2="1"><s1>HOFFMAN (Robert S.)</s1>
</fA11>
<fA11 i1="05" i2="1"><s1>HOLLANDER (Judd E.)</s1>
</fA11>
<fA11 i1="06" i2="1"><s1>JAEGER (Albert)</s1>
</fA11>
<fA11 i1="07" i2="1"><s1>KERN (William II)</s1>
</fA11>
<fA11 i1="08" i2="1"><s1>MARTIN (Thomas G.)</s1>
</fA11>
<fA11 i1="09" i2="1"><s1>ROSS (Mitchell P.)</s1>
</fA11>
<fA14 i1="01"><s1>University of California Davis Medical Center</s1>
<s2>Sacramento, CA</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
</fA14>
<fA14 i1="02"><s1>Newcastle Mater Misericordiae Hospital</s1>
<s2>Newcastle</s2>
<s3>AUS</s3>
<sZ>2 aut.</sZ>
</fA14>
<fA14 i1="03"><s1>Universitario Val d'Hebron</s1>
<s2>Barcelona</s2>
<s3>ESP</s3>
<sZ>3 aut.</sZ>
</fA14>
<fA14 i1="04"><s1>New York Poison Center</s1>
<s2>New York, NY</s2>
<s3>USA</s3>
<sZ>4 aut.</sZ>
</fA14>
<fA14 i1="05"><s1>University of Pennsylvania</s1>
<s2>Philadelphia, PA</s2>
<s3>USA</s3>
<sZ>5 aut.</sZ>
</fA14>
<fA14 i1="06"><s1>Hospitaux Universitaires de Strasbourg</s1>
<s2>Strasbourg</s2>
<s3>FRA</s3>
<sZ>6 aut.</sZ>
</fA14>
<fA14 i1="07"><s1>Carolinas Medical Center</s1>
<s2>Charlotte, NC</s2>
<s3>USA</s3>
<sZ>7 aut.</sZ>
</fA14>
<fA14 i1="08"><s1>University of Washington Medical Center</s1>
<s2>Seattle, WA</s2>
<s3>USA</s3>
<sZ>8 aut.</sZ>
</fA14>
<fA14 i1="09"><s1>University of Louisville</s1>
<s2>Louisville, KY</s2>
<s3>USA</s3>
<sZ>9 aut.</sZ>
</fA14>
<fA20><s2>S78-S90</s2>
</fA20>
<fA21><s1>2001</s1>
</fA21>
<fA23 i1="01"><s0>ENG</s0>
</fA23>
<fA43 i1="01"><s1>INIST</s1>
<s2>19670</s2>
<s5>354000098814500100</s5>
</fA43>
<fA44><s0>0000</s0>
<s1>© 2001 INIST-CNRS. All rights reserved.</s1>
</fA44>
<fA45><s0>110 ref.</s0>
</fA45>
<fA47 i1="01" i2="1"><s0>01-0247194</s0>
</fA47>
<fA60><s1>P</s1>
</fA60>
<fA61><s0>A</s0>
</fA61>
<fA64 i1="01" i2="1"><s0>Annals of emergency medicine</s0>
</fA64>
<fA66 i1="01"><s0>USA</s0>
</fA66>
<fC02 i1="01" i2="X"><s0>002B27B15</s0>
</fC02>
<fC02 i1="02" i2="X"><s0>002B02V</s0>
</fC02>
<fC03 i1="01" i2="X" l="FRE"><s0>Toxicomanie</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="ENG"><s0>Drug addiction</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="SPA"><s0>Toxicomanía</s0>
<s5>01</s5>
</fC03>
<fC03 i1="02" i2="X" l="FRE"><s0>Intoxication médicamenteuse</s0>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="ENG"><s0>Drug intoxication</s0>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="SPA"><s0>Intoxicación medicamentosa</s0>
<s5>02</s5>
</fC03>
<fC03 i1="03" i2="X" l="FRE"><s0>Cocaïne</s0>
<s2>NK</s2>
<s2>FR</s2>
<s2>FX</s2>
<s5>04</s5>
</fC03>
<fC03 i1="03" i2="X" l="ENG"><s0>Cocaine</s0>
<s2>NK</s2>
<s2>FR</s2>
<s2>FX</s2>
<s5>04</s5>
</fC03>
<fC03 i1="03" i2="X" l="SPA"><s0>Cocaína</s0>
<s2>NK</s2>
<s2>FR</s2>
<s2>FX</s2>
<s5>04</s5>
</fC03>
<fC03 i1="04" i2="X" l="FRE"><s0>Opiacés</s0>
<s5>05</s5>
</fC03>
<fC03 i1="04" i2="X" l="ENG"><s0>Opiates</s0>
<s5>05</s5>
</fC03>
<fC03 i1="04" i2="X" l="SPA"><s0>Opiados</s0>
<s5>05</s5>
</fC03>
<fC03 i1="05" i2="X" l="FRE"><s0>Antagoniste calcium</s0>
<s5>07</s5>
</fC03>
<fC03 i1="05" i2="X" l="ENG"><s0>Calcium antagonist</s0>
<s5>07</s5>
</fC03>
<fC03 i1="05" i2="X" l="SPA"><s0>Antagonista calcio</s0>
<s5>07</s5>
</fC03>
<fC03 i1="06" i2="X" l="FRE"><s0>Stimulant β-adrénergique</s0>
<s5>08</s5>
</fC03>
<fC03 i1="06" i2="X" l="ENG"><s0>β-Adrenergic receptor agonist</s0>
<s5>08</s5>
<s6>«β»-Adrenergic receptor agonist</s6>
</fC03>
<fC03 i1="06" i2="X" l="SPA"><s0>Estimulante β-adrenérgico</s0>
<s5>08</s5>
</fC03>
<fC03 i1="07" i2="X" l="FRE"><s0>Récepteur β-adrénergique</s0>
<s5>09</s5>
</fC03>
<fC03 i1="07" i2="X" l="ENG"><s0>β-Adrenergic receptor</s0>
<s5>09</s5>
<s6>«β-»Adrenergic receptor</s6>
</fC03>
<fC03 i1="07" i2="X" l="SPA"><s0>Receptor β-adrenérgico</s0>
<s5>09</s5>
</fC03>
<fC03 i1="08" i2="X" l="FRE"><s0>Insuffisance respiratoire</s0>
<s5>10</s5>
</fC03>
<fC03 i1="08" i2="X" l="ENG"><s0>Respiratory failure</s0>
<s5>10</s5>
</fC03>
<fC03 i1="08" i2="X" l="SPA"><s0>Insuficiencia respiratoria</s0>
<s5>10</s5>
</fC03>
<fC03 i1="09" i2="X" l="FRE"><s0>Antidépresseur</s0>
<s5>11</s5>
</fC03>
<fC03 i1="09" i2="X" l="ENG"><s0>Antidepressant agent</s0>
<s5>11</s5>
</fC03>
<fC03 i1="09" i2="X" l="SPA"><s0>Antidepresor</s0>
<s5>11</s5>
</fC03>
<fC03 i1="10" i2="X" l="FRE"><s0>Composé tricyclique</s0>
<s5>12</s5>
</fC03>
<fC03 i1="10" i2="X" l="ENG"><s0>Tricyclic compound</s0>
<s5>12</s5>
</fC03>
<fC03 i1="10" i2="X" l="SPA"><s0>Compuesto tricíclico</s0>
<s5>12</s5>
</fC03>
<fC03 i1="11" i2="X" l="FRE"><s0>Cardiotonique</s0>
<s5>13</s5>
</fC03>
<fC03 i1="11" i2="X" l="ENG"><s0>Cardiotonic agent</s0>
<s5>13</s5>
</fC03>
<fC03 i1="11" i2="X" l="SPA"><s0>Cardiotónico</s0>
<s5>13</s5>
</fC03>
<fC03 i1="12" i2="X" l="FRE"><s0>Complication</s0>
<s5>16</s5>
</fC03>
<fC03 i1="12" i2="X" l="ENG"><s0>Complication</s0>
<s5>16</s5>
</fC03>
<fC03 i1="12" i2="X" l="SPA"><s0>Complicación</s0>
<s5>16</s5>
</fC03>
<fC03 i1="13" i2="X" l="FRE"><s0>Recommandation</s0>
<s5>17</s5>
</fC03>
<fC03 i1="13" i2="X" l="ENG"><s0>Recommendation</s0>
<s5>17</s5>
</fC03>
<fC03 i1="13" i2="X" l="SPA"><s0>Recomendación</s0>
<s5>17</s5>
</fC03>
<fC03 i1="14" i2="X" l="FRE"><s0>Traitement</s0>
<s5>18</s5>
</fC03>
<fC03 i1="14" i2="X" l="ENG"><s0>Treatment</s0>
<s5>18</s5>
</fC03>
<fC03 i1="14" i2="X" l="SPA"><s0>Tratamiento</s0>
<s5>18</s5>
</fC03>
<fC03 i1="15" i2="X" l="FRE"><s0>Evolution</s0>
<s5>19</s5>
</fC03>
<fC03 i1="15" i2="X" l="ENG"><s0>Evolution</s0>
<s5>19</s5>
</fC03>
<fC03 i1="15" i2="X" l="SPA"><s0>Evolución</s0>
<s5>19</s5>
</fC03>
<fC03 i1="16" i2="X" l="FRE"><s0>Homme</s0>
<s5>20</s5>
</fC03>
<fC03 i1="16" i2="X" l="ENG"><s0>Human</s0>
<s5>20</s5>
</fC03>
<fC03 i1="16" i2="X" l="SPA"><s0>Hombre</s0>
<s5>20</s5>
</fC03>
<fC03 i1="17" i2="X" l="FRE"><s0>Ester</s0>
<s5>27</s5>
</fC03>
<fC03 i1="17" i2="X" l="ENG"><s0>Ester</s0>
<s5>27</s5>
</fC03>
<fC03 i1="17" i2="X" l="SPA"><s0>Ester</s0>
<s5>27</s5>
</fC03>
<fC07 i1="01" i2="X" l="FRE"><s0>Appareil respiratoire pathologie</s0>
<s5>61</s5>
</fC07>
<fC07 i1="01" i2="X" l="ENG"><s0>Respiratory disease</s0>
<s5>61</s5>
</fC07>
<fC07 i1="01" i2="X" l="SPA"><s0>Aparato respiratorio patología</s0>
<s5>61</s5>
</fC07>
<fN21><s1>169</s1>
</fN21>
</pA>
</standard>
<server><NO>PASCAL 01-0247194 INIST</NO>
<ET>TOX-ACLS: Toxicologic-oriented advanced cardiac life support</ET>
<AU>ALBERTSON (Timothy E.); DAWSON (Andrew); DE LATORRE (Francisco); HOFFMAN (Robert S.); HOLLANDER (Judd E.); JAEGER (Albert); KERN (William II); MARTIN (Thomas G.); ROSS (Mitchell P.)</AU>
<AF>University of California Davis Medical Center/Sacramento, CA/Etats-Unis (1 aut.); Newcastle Mater Misericordiae Hospital/Newcastle/Australie (2 aut.); Universitario Val d'Hebron/Barcelona/Espagne (3 aut.); New York Poison Center/New York, NY/Etats-Unis (4 aut.); University of Pennsylvania/Philadelphia, PA/Etats-Unis (5 aut.); Hospitaux Universitaires de Strasbourg/Strasbourg/France (6 aut.); Carolinas Medical Center/Charlotte, NC/Etats-Unis (7 aut.); University of Washington Medical Center/Seattle, WA/Etats-Unis (8 aut.); University of Louisville/Louisville, KY/Etats-Unis (9 aut.)</AF>
<DT>Publication en série; Niveau analytique</DT>
<SO>Annals of emergency medicine; ISSN 0196-0644; Coden AEMED3; Etats-Unis; Da. 2001; Vol. 37; No. 4 SUP; S78-S90; Bibl. 110 ref.</SO>
<LA>Anglais</LA>
<CC>002B27B15; 002B02V</CC>
<FD>Toxicomanie; Intoxication médicamenteuse; Cocaïne; Opiacés; Antagoniste calcium; Stimulant β-adrénergique; Récepteur β-adrénergique; Insuffisance respiratoire; Antidépresseur; Composé tricyclique; Cardiotonique; Complication; Recommandation; Traitement; Evolution; Homme; Ester</FD>
<FG>Appareil respiratoire pathologie</FG>
<ED>Drug addiction; Drug intoxication; Cocaine; Opiates; Calcium antagonist; β-Adrenergic receptor agonist; β-Adrenergic receptor; Respiratory failure; Antidepressant agent; Tricyclic compound; Cardiotonic agent; Complication; Recommendation; Treatment; Evolution; Human; Ester</ED>
<EG>Respiratory disease</EG>
<SD>Toxicomanía; Intoxicación medicamentosa; Cocaína; Opiados; Antagonista calcio; Estimulante β-adrenérgico; Receptor β-adrenérgico; Insuficiencia respiratoria; Antidepresor; Compuesto tricíclico; Cardiotónico; Complicación; Recomendación; Tratamiento; Evolución; Hombre; Ester</SD>
<LO>INIST-19670.354000098814500100</LO>
<ID>01-0247194</ID>
</server>
</inist>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/PascalFrancis/Corpus

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 005C05 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Corpus/biblio.hfd -nk 005C05 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Asie
   |area=    AustralieFrV1
   |flux=    PascalFrancis
   |étape=   Corpus
   |type=    RBID
   |clé=     Pascal:01-0247194
   |texte=   TOX-ACLS: Toxicologic-oriented advanced cardiac life support
}}

This area was generated with Dilib version V0.6.33.
Data generation: Tue Dec 5 10:43:12 2017. Site generation: Tue Mar 5 14:07:20 2024

	Serveur d'exploration sur les relations entre la France et l'Australie
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Serveur d'exploration sur les relations entre la France et l'Australie

TOX-ACLS: Toxicologic-oriented advanced cardiac life support

TOX-ACLS: Toxicologic-oriented advanced cardiac life support

Source :

Descripteurs français

English descriptors

Notice en format standard (ISO 2709)

Format Inist (serveur)

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri